Skip to content

A multicenter, prospective, randomised study of "covered" versus "uncovered" stents for the management of distal malignant biliary obstruction

A multicenter, prospective, randomised study of "covered" versus "uncovered" stents for the management of distal malignant biliary obstruction - A multicenter randomized controlled trial of metallic stent for unresectable distal malignant biliary obstruction

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008587
Enrollment
200
Registered
2012-09-01
Start date
2012-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant biliary obstruction

Interventions

WallFlex Fully-covered biliary stent WallFlex Uncovered biliary stent

Sponsors

Faculty of Medicine, Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with unresectable distal malignant biliary obstruction, not limited to primary disease. 2) Patients with predictable prognosis of more than 4 months. 3) Patients with written informed consent. 4) Patients with performance status 0-3.

Exclusion criteria

Exclusion criteria: 1) Patients with massive ascites. 2) Patients with severely impaired organ function. 3) Patients for whom endoscopic biliary drainage is difficult. 4) Patients with duodenal obstruction. 5) Patients whose antithrombotic drugs cannot be stopped. 6) Patients considered ineligible for this study.

Design outcomes

Primary

MeasureTime frame
Time to stent dysfunction

Secondary

MeasureTime frame
Effectiveness 1) Stent patency period 2) Survival period 3) Event free survival 4) Stent patency period after reintervention 5) Time to stent dysfunction after reintervention 6) Cost effectiveness Safety 1) Early complications 2) Late complications 3) Technical success rate 4) Removability of the stent 5) Removability of the second stent

Countries

Japan

Contacts

Public ContactAkira Kurita

Faculty of Medicine, Kyoto University Department of Gastroenterology and Hepatology

akurita@kuhp.kyoto-u.ac.jp075-751-4319

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026